Engin Kut

7PUBLICATIONS
93CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

|May 27, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|Mar 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur

|Dec 05, 2025
Prognostic relationship of peripheral blood-immune inflammatory index (C-PLAN) in patients with high-grade glioma.

Murtaza Parvizi, Olcay Ak Nalbant, Engin Kut

|Aug 05, 2025
Evaluation of pre-treatment F-18 FDG PET/CT according to Mandard classification in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiotherapy.

Feray Aras, Murtaza Parvizi, Olcay Ak Nalbant

|Jan 16, 2024
Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.

Engin Kut, Serkan Menekse

Pageof 2

Frequent Collaborators

3 joint publications

Serkan Menekşe

2 joint publications

Emine Türkmen

2 joint publications

Murtaza Parvizi

2 joint publications

Olcay Ak Nalbant